FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894745368> ?p ?o ?g. }

• W2894745368 endingPage "2876" @default.
• W2894745368 startingPage "2867" @default.
• W2894745368 abstract "Aims SNF472 is a calcification inhibitor being developed for the treatment of cardiovascular calcification in haemodialysis (HD) and in calciphylaxis patients. This study investigated the safety, tolerability and pharmacokinetics (PK) of intravenous (IV) SNF472 in healthy volunteers (HV) and HD patients. Methods This is a first‐time‐in‐human, double‐blind, randomized, placebo‐controlled Phase I study to assess the safety, tolerability and PK of SNF472 after ascending single IV doses in HV and a single IV dose in HD patients. A pharmacodynamic analysis was performed to assess the capability of IV SNF472 to inhibit hydroxyapatite formation. Results Twenty HV and eight HD patients were enrolled. The starting dose in HV was 0.5 mg kg –1 and the dose ascended to 12.5 mg kg –1 . The dose selected for HD patients was 9 mg kg –1 . Safety analyses support the safety and tolerability of IV SNF472 in HD patients and HV. Most treatment‐emergent adverse events were mild in intensity. No clinically significant effects were observed on vital signs or laboratory tests. PK results were similar in HD patients and HV and indicate a lack of significant dialysability. Pharmacodynamic analyses demonstrated that SNF472 administration reduced hydroxyapatite crystallization potential in HD patients who received IV SNF472 9 mg kg –1 by 80.0 ± 2.4% (mean ± standard error of the mean, 95% CI, 75.3–84.8) compared to placebo (8.7 ± 21.0%, P < 0.001, 95% CI, –32.4 to 49.7). Conclusion The results from this study showed acceptable safety and tolerability, and lack of significant dialysability of IV SNF472. It is a potential novel treatment for cardiovascular calcification in end‐stage renal disease and calciphylaxis warranting further human studies." @default.
• W2894745368 created "2018-10-12" @default.
• W2894745368 creator A5012238804 @default.
• W2894745368 creator A5042417670 @default.
• W2894745368 creator A5057716949 @default.
• W2894745368 creator A5074824671 @default.
• W2894745368 creator A5075969414 @default.
• W2894745368 creator A5086776835 @default.
• W2894745368 date "2018-10-03" @default.
• W2894745368 modified "2023-10-10" @default.
• W2894745368 title "First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification" @default.
• W2894745368 cites W1964465210 @default.
• W2894745368 cites W1965434441 @default.
• W2894745368 cites W1965825226 @default.
• W2894745368 cites W1971192507 @default.
• W2894745368 cites W1979587730 @default.
• W2894745368 cites W2023653442 @default.
• W2894745368 cites W2024635160 @default.
• W2894745368 cites W2037099425 @default.
• W2894745368 cites W2045847718 @default.
• W2894745368 cites W2055762940 @default.
• W2894745368 cites W2081497794 @default.
• W2894745368 cites W2083847691 @default.
• W2894745368 cites W2084101223 @default.
• W2894745368 cites W2095804181 @default.
• W2894745368 cites W2112390805 @default.
• W2894745368 cites W2116525521 @default.
• W2894745368 cites W2132589733 @default.
• W2894745368 cites W2136690392 @default.
• W2894745368 cites W2150208064 @default.
• W2894745368 cites W2201264930 @default.
• W2894745368 cites W2295642769 @default.
• W2894745368 cites W2478260148 @default.
• W2894745368 cites W2520379192 @default.
• W2894745368 cites W2737179268 @default.
• W2894745368 cites W2771328536 @default.
• W2894745368 doi "https://doi.org/10.1111/bcp.13752" @default.
• W2894745368 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6255995" @default.
• W2894745368 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30280390" @default.
• W2894745368 hasPublicationYear "2018" @default.
• W2894745368 type Work @default.
• W2894745368 sameAs 2894745368 @default.
• W2894745368 citedByCount "23" @default.
• W2894745368 countsByYear W28947453682019 @default.
• W2894745368 countsByYear W28947453682020 @default.
• W2894745368 countsByYear W28947453682021 @default.
• W2894745368 countsByYear W28947453682022 @default.
• W2894745368 countsByYear W28947453682023 @default.
• W2894745368 crossrefType "journal-article" @default.
• W2894745368 hasAuthorship W2894745368A5012238804 @default.
• W2894745368 hasAuthorship W2894745368A5042417670 @default.
• W2894745368 hasAuthorship W2894745368A5057716949 @default.
• W2894745368 hasAuthorship W2894745368A5074824671 @default.
• W2894745368 hasAuthorship W2894745368A5075969414 @default.
• W2894745368 hasAuthorship W2894745368A5086776835 @default.
• W2894745368 hasBestOaLocation W28947453681 @default.
• W2894745368 hasConcept C111113717 @default.
• W2894745368 hasConcept C112705442 @default.
• W2894745368 hasConcept C126322002 @default.
• W2894745368 hasConcept C126894567 @default.
• W2894745368 hasConcept C141071460 @default.
• W2894745368 hasConcept C142724271 @default.
• W2894745368 hasConcept C168563851 @default.
• W2894745368 hasConcept C197934379 @default.
• W2894745368 hasConcept C204787440 @default.
• W2894745368 hasConcept C27081682 @default.
• W2894745368 hasConcept C2776954043 @default.
• W2894745368 hasConcept C2778063415 @default.
• W2894745368 hasConcept C2778375690 @default.
• W2894745368 hasConcept C2780309369 @default.
• W2894745368 hasConcept C71924100 @default.
• W2894745368 hasConcept C90924648 @default.
• W2894745368 hasConceptScore W2894745368C111113717 @default.
• W2894745368 hasConceptScore W2894745368C112705442 @default.
• W2894745368 hasConceptScore W2894745368C126322002 @default.
• W2894745368 hasConceptScore W2894745368C126894567 @default.
• W2894745368 hasConceptScore W2894745368C141071460 @default.
• W2894745368 hasConceptScore W2894745368C142724271 @default.
• W2894745368 hasConceptScore W2894745368C168563851 @default.
• W2894745368 hasConceptScore W2894745368C197934379 @default.
• W2894745368 hasConceptScore W2894745368C204787440 @default.
• W2894745368 hasConceptScore W2894745368C27081682 @default.
• W2894745368 hasConceptScore W2894745368C2776954043 @default.
• W2894745368 hasConceptScore W2894745368C2778063415 @default.
• W2894745368 hasConceptScore W2894745368C2778375690 @default.
• W2894745368 hasConceptScore W2894745368C2780309369 @default.
• W2894745368 hasConceptScore W2894745368C71924100 @default.
• W2894745368 hasConceptScore W2894745368C90924648 @default.
• W2894745368 hasFunder F4320321837 @default.
• W2894745368 hasIssue "12" @default.
• W2894745368 hasLocation W28947453681 @default.
• W2894745368 hasLocation W28947453682 @default.
• W2894745368 hasLocation W28947453683 @default.
• W2894745368 hasOpenAccess W2894745368 @default.
• W2894745368 hasPrimaryLocation W28947453681 @default.
• W2894745368 hasRelatedWork W1563120570 @default.
• W2894745368 hasRelatedWork W2089217516 @default.
• W2894745368 hasRelatedWork W2141043112 @default.

• next